Vivos (RDGL) Cash & Equivalents (2010 - 2025)
Vivos (RDGL) recorded Cash & Equivalents of $1.56 million in Q4 2025, down 29.6% from $2.21 million a year earlier and down 29.2% from the prior quarter.
Powered by 
Analysis
Vivos (RDGL) Cash & Equivalents (2010 - 2025) Analysis & Trends
Starting with Q2 2010, Vivos' Cash & Equivalents history includes 57 quarters.
- Annual Cash & Equivalents has a five-year compound annual growth rate of 11.5% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $2.21 million in FY2024 (+39.0%), $1.59 million in FY2023 (-6.7%), $1.71 million in FY2022 (+6.2%) and $1.61 million in FY2021 (+77.7%).
- The Q4 2025 figure is the lowest quarterly Cash & Equivalents since Q3 2024.
- On a year-over-year basis, Cash & Equivalents rose in four of the last eight quarters, with growth averaging 32.2%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 769.9% in Q2 2021, against a decline of 51.5% in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.2 million (Q3 2025), $2.66 million (Q2 2025) and $3.27 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 242.18 Bn | 221.33 Bn | 4.88 Bn | 4.06 Bn |
| 2 | Abbott Laboratories | 168.71 Bn | 139.79 Bn | 7.27 Bn | 5.10 Bn |
| 3 | Danaher | 150.46 Bn | 134.27 Bn | 3.61 Bn | 4.35 Bn |
| 4 | Intuitive Surgical | 138.71 Bn | 118.26 Bn | 1.96 Bn | 2.76 Bn |
| 5 | Medtronic | 110.54 Bn | 76.41 Bn | 6.34 Bn | 1.69 Bn |
| 6 | Stryker | 105.66 Bn | 91.78 Bn | 4.50 Bn | 3.39 Bn |
| 7 | Boston Scientific | 61.74 Bn | 56.75 Bn | 3.85 Bn | 539.00 Mn |
| 8 | Edwards Lifesciences | 49.09 Bn | 33.21 Bn | 1.35 Bn | 2.91 Bn |
| 9 | Becton Dickinson | 48.16 Bn | 45.31 Bn | 2.32 Bn | 708.00 Mn |
| 10 | Vivos | 22.77 Mn | 13.09 Mn | -3,105.00 | 1.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.56 Mn |
| Sep 30, 2025 | 2.20 Mn |
| Jun 30, 2025 | 2.66 Mn |
| Mar 31, 2025 | 3.27 Mn |
| Dec 31, 2024 | 2.21 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 1.72 Mn |
| Mar 31, 2024 | 1.37 Mn |
| Dec 31, 2023 | 1.59 Mn |
| Sep 30, 2023 | 1.54 Mn |
| Jun 30, 2023 | 1.75 Mn |
| Mar 31, 2023 | 1.41 Mn |
| Dec 31, 2022 | 1.71 Mn |
| Sep 30, 2022 | 1.99 Mn |
| Jun 30, 2022 | 1.05 Mn |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 1.61 Mn |
| Sep 30, 2021 | 1.99 Mn |
| Jun 30, 2021 | 2.16 Mn |
| Mar 31, 2021 | 2.51 Mn |
API Access
Vivos Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RDGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "RDGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RDGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();